Morgan Stanley’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Buy |
|
|||||
|
2025
Q1 | $9.22M | Sell |
|
|||||
|
2024
Q4 | $10M | Sell |
|
|||||
|
2024
Q3 | $12.6M | Buy |
|
|||||
|
2024
Q2 | $2.63M | Sell |
|
|||||
|
2024
Q1 | $2.87M | Sell |
|
|||||
|
2023
Q4 | $3.68M | Buy |
|
|||||
|
2023
Q3 | $1.04M | Sell |
|
|||||
|
2023
Q2 | $1.49M | Sell |
|
|||||
|
2023
Q1 | $1.35M | Buy |
|
|||||
|
2022
Q4 | $930K | Sell |
|
|||||
|
2022
Q3 | $418K | Buy |
|
|||||
|
2022
Q2 | $209K | Sell |
|
|||||
|
2022
Q1 | $803K | Sell |
|
|||||
|
2021
Q4 | $963K | Buy |
|
|||||
|
2021
Q3 | $1.39M | Buy |
|
|||||
|
2021
Q2 | $1.62M | Buy |
|
|||||
|
2021
Q1 | $1.26M | Sell |
|
|||||
|
2020
Q4 | $1.19M | Buy |
|
|||||
|
2020
Q3 | $723K | Buy |
|
|||||
|
2020
Q2 | $355K | Sell |
|
|||||
|
2020
Q1 | $464K | Sell |
|
|||||
|
2019
Q4 | $374K | Buy |
|
|||||
|
2019
Q3 | $408K | Sell |
|
|||||
|
2019
Q2 | $309K | Buy |
|
|||||
|
2019
Q1 | $417K | Buy |
|
|||||
|
2018
Q4 | $262K | Sell |
|
|||||
|
2018
Q3 | $507K | Sell |
|
|||||
|
2018
Q2 | $559K | Sell |
|
|||||
|
2018
Q1 | $2.96M | Buy |
|
|||||
|
2017
Q4 | $765K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $89K | Buy |
|
|||||
|
2016
Q4 | $34K | Buy |
|
|||||
|
2016
Q3 | $2K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $0 | Sell |
|
|||||
|
2015
Q4 | $0 | Sell |
|
|||||
|
2015
Q3 | $0 | Buy |
|
|||||
|
2015
Q2 | $0 | Buy |
|